EyePoint Pharmaceuticals vs SonoThera

EyePoint Pharmaceuticals vs SonoThera, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: EyePoint Pharmaceuticals is on 36/100 and SonoThera on 53/100.

EyePoint Pharmaceuticals logo
EyePoint PharmaceuticalsOphthalmology-focused biopharmaceutical company developing sustained-release drug delivery systems for serious eye diseases.
Try EyePoint Pharmaceuticals
SonoThera logo
SonoTheraDeveloping ultrasound-mediated nonviral genetic medicines.
Try SonoThera

Where each one leads

EyePoint Pharmaceuticals

  • agent readiness: 50/100 against 21/100
  • domain rating: 43/100 against 25/100
  • funding raised: $436M against $125M

SonoThera

  • our overall score: 53/100 against 36/100

At a glance

MeasureEyePoint PharmaceuticalsSonoThera
What it isOphthalmology-focused biopharmaceutical company developing sustained-release drug delivery systems for serious eye diseases.Developing ultrasound-mediated nonviral genetic medicines.
CategoryBiotechnology, Biopharmaceuticals, Specialty Pharmaceuticals, OphthalmologyBiotechnology, Healthcare, Gene Therapy, Medical Devices
Sells toBusiness modelB2BB2B
OfferingSoftware | hardware | services | marketplace | platformServices
Founded19872019
HeadquartersWatertown, United StatesSan Francisco, USA
StatusInactiveActive

Size, funding and growth

MeasureEyePoint PharmaceuticalsSonoThera
EmployeesNot published54
Total funding$436M$125M
Latest roundPublic OfferingSeries B
LinkedIn followersNot published5,837

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureEyePoint PharmaceuticalsSonoThera
StartupHub scoreOur 0-100 rating36/10053/100
Traction40/10057/100
Team30/100Not published
Search visibility13/10033/100
Quality40/10068/100
Agent readinessHow well an AI agent can read and act on the siteD (50/100)F (21/100)
Domain ratingLink authority, 0-10043/10025/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureEyePoint PharmaceuticalsSonoThera
HostingGoogle CloudNot detected
CDNNot detectedCloudflare
CMSNot detectedWordPress
FrameworksNot detectedJquery
AnalyticsNot detectedGoogle Analytics 4, Jetpack Stats

What users say

MeasureEyePoint PharmaceuticalsSonoThera
Reddit sentimentThreads we trackNot published1 positive, 0 negative across 1 thread
SonoThera
SonoThera™ to Present New Data at ASGCT 2025 Demonstrating the Potential of Genetic Medicine Using Targeted, Ultrasound-Mediated Delivery in Treating Duchenne Muscular Dystrophy and Hemophilia A.
r/Hemophilia

EyePoint Pharmaceuticals vs SonoThera: common questions

Which is better, EyePoint Pharmaceuticals or SonoThera?

On our 0-100 score SonoThera rates higher (53/100 against 36/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.

How do EyePoint Pharmaceuticals and SonoThera compare on the numbers?

EyePoint Pharmaceuticals leads on agent readiness (50/100 against 21/100), domain rating (43/100 against 25/100), funding raised ($436M against $125M). SonoThera leads on our overall score (53/100 against 36/100).

What do real users say about EyePoint Pharmaceuticals and SonoThera?

SonoThera: 1 positive and 0 negative mentions across 1 Reddit threads we track, mostly in r/Hemophilia.

Read the full EyePoint Pharmaceuticals review and pricing or the SonoThera review and pricing. You can also browse other EyePoint Pharmaceuticals alternatives we track.